Korsana Biosciences: Series ADevelops novel therapies to reduce the burden of neurodegenerative diseasesOct 4, 2026RoundOSKorsana BiosciencesCompany profile and funding historySourcesbusinesswire.comMore in BiotechAusperBio · Series CProFound Therapeutics · StrategicTransfyr · SeedBiotechUnited StatesHealthtechNorth AmericaSeries A